HCPCS Level II · Procedures and professional services (temporary)
G9018Zanamivir, inhalation powder, administered through inhaler, per 10 mg (for use in a medicare-approved demonstration project)
Terminated 12/31/2019
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About G9018
G9018 is an HCPCS Level II code in the G series (procedures and professional services (temporary)), describing zanamivir, inhalation powder, administered through inhaler, per 10 mg (for use in a medicare-approved demonstration project).
It was added to HCPCS effective 12/01/2004, and its current record took effect 01/01/2020.
It was terminated on 12/31/2019 and can't be billed for later dates of service.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- Zanamivir,inhalation pwd 10m
- Date added
- 12/01/2004
- Action effective
- 01/01/2020
- Termination date
- 12/31/2019
- BETOS
- O1E
Related G90xx codes
- G9001Coordinated care fee, initial rate
- G9002Coordinated care fee, maintenance rate
- G9003Coordinated care fee, risk adjusted high, initial
- G9004Coordinated care fee, risk adjusted low, initial
- G9005Coordinated care fee, risk adjusted maintenance
- G9006Coordinated care fee, home monitoring
- G9007Coordinated care fee, scheduled team conference
- G9008Coordinated care fee, physician coordinated care oversight services
- G9009Coordinated care fee, risk adjusted maintenance, level 3
- G9010Coordinated care fee, risk adjusted maintenance, level 4
- G9011Coordinated care fee, risk adjusted maintenance, level 5
- G9012Other specified case management service not elsewhere classified
Common questions about G9018
Is HCPCS G9018 still valid?
- No. G9018 was terminated on 12/31/2019.
Does Medicare cover G9018?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.